Home Tags Immunotherapy

Tag: immunotherapy

Attendees and Speakers during Friday Scientific Workshop on Tumor Immune Interactions in Lymphoid Malignancies at the American Society of Hematology 60th Annual Meeting at the Orange County Convention Center on, Friday December 6, 2019. Photo courtesy © 2019 ASH/Matt Herp 2019

ASH 2019: Second-gen CAR T-Cell Therapy Overcome Resistance, Reduce Toxicity and...

Peter Hofland, Ph.D -

Enfortumab Vedotin + Pembrolizumab to be Evaluated in Metastatic Bladder Cancer

Peter Hofland, Ph.D -
SurVaxM. Photo Courtesy: 2019 Roswell Park.

Large Phase II Study to Investigate SurVaxM in Glioblastoma in China...

Peter Hofland, Ph.D -
Doctor discussing treatment options with a patient.

Erdafitinib, the First-Ever Targeted Therapy for Bladder Cancer, Receives Accelerated FDA...

Adil J. Akhtar, MD -
Blood

First Patient Enrolled in Non-Pharmaceutical Multi-Center, Triple-Negative Breast Cancer Clinical Trial

Peter Hofland, Ph.D -
Netherlands Cancer Institute in Amsterdam, The Netherlands

Prioritizing the Importance of the Immune System

Danielle Garcia -

Pembrolizumab as 1st-line Therapy for Merkel Cell Carcinoma Shows Improved Survival

Peter Hofland, Ph.D -

Pembrolizumab Improves Survival of Patients with Metastatic or Recurrent Head and...

Peter Hofland, Ph.D -

Immunotherapy-chemotherapy Combination Improves Treatment of Aggressive Breast Cancer

Danielle Garcia -

New Data Supports Use of Real-World Evidence to Assess Long-term Impact...

Peter Hofland, Ph.D -
12Page 1 of 2

LATEST

© 2019 Sunvalley Communication, LLC. All Rights Reserved.